DI MASCIO, MARIA TERESA
 Distribuzione geografica
Continente #
NA - Nord America 571
EU - Europa 286
AS - Asia 119
AF - Africa 6
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 990
Nazione #
US - Stati Uniti d'America 569
IT - Italia 140
SE - Svezia 51
CN - Cina 42
SG - Singapore 38
IN - India 35
FI - Finlandia 23
UA - Ucraina 19
DE - Germania 18
FR - Francia 10
BE - Belgio 6
GB - Regno Unito 6
AR - Argentina 5
NL - Olanda 4
TG - Togo 4
KR - Corea 3
CA - Canada 2
IE - Irlanda 2
PL - Polonia 2
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
EG - Egitto 1
EU - Europa 1
JP - Giappone 1
RO - Romania 1
RS - Serbia 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 990
Città #
Fairfield 92
Chandler 56
Woodbridge 51
Rome 47
Ashburn 36
Beijing 33
Houston 29
Princeton 24
Wilmington 24
Singapore 22
Cambridge 21
Plano 18
Seattle 18
San Paolo di Civitate 16
Ann Arbor 12
Millbury 12
Boston 11
Lawrence 9
Jacksonville 8
Andover 6
San Diego 6
Federal 5
Norwalk 5
Bologna 4
Brussels 4
Dearborn 4
Lomé 4
Reggio Calabria 4
San Mateo 4
Sant'Antonio Abate 4
Bolzano 3
Collecchio 3
Helsinki 3
Nichelino 3
Paris 3
Waltham 3
Boardman 2
Bühl 2
Dublin 2
Ladispoli 2
Lappeenranta 2
Los Angeles 2
Montigny-le-Bretonneux 2
Nanjing 2
Naples 2
New York 2
Salisbury 2
Santa Clara 2
Seoul 2
Sora 2
Toulouse 2
Waanrode 2
Aargau 1
Amsterdam 1
Bremen 1
Dallas 1
Des Moines 1
Falls Church 1
Fiuggi 1
Frankfurt am Main 1
Fremont 1
Fuzhou 1
Garden City 1
Hamburg 1
Hefei 1
Indiana 1
Islington 1
Jinan 1
Kragujevac 1
Kunming 1
Laurel 1
Leawood 1
Lido 1
Limite 1
Milan 1
Muizenberg 1
New Haven 1
Nürnberg 1
Ottawa 1
Pastrengo 1
Perugia 1
Prescot 1
Roda 1
Seversk 1
Simi Valley 1
Sofia 1
Southend 1
Suwon 1
Tokyo 1
Toronto 1
Vasto 1
Vilshofen 1
Warsaw 1
Totale 680
Nome #
Vaccine-induced immune thrombotic thrombocytopenia and spike protein 101
May stroke cause a Complex Sleep Apnea-CompSA? 92
Vaccine-induced immune thrombotic thrombocytopenia: a possible pathogenetic role of ChAdOx1 nCoV-19 vaccine encoded soluble SARS-CoV-2 spike protein 78
MRI and polysomnographic findings of patients affected by post-stroke sleep apnea 69
Thalamic connectivity in patients with sleep-disordered breathing (SDB) after stroke 69
Genetic screening of Anderson-Fabry disease in probands referred from multispecialty clinics 65
Types of stroke recurrence in patients with ischemic stroke: a substudy from the PRoFESS trial. 57
Sleep Disordered Breathing after Stroke: Clinical Profile of Patients with Obstructive- as Opposed to Central-Sleep Apnea 56
CD4+ CD28null T cell role in atherosclerotic plaque development 45
Targeting stroke awareness public campaigns 42
VASCULAR RISK FACTORS IN YOUNG PEOPLE: RESULTS FROM AN OBSERVATIONAL STUDY 41
Resting state functional thalamic connectivity abnormalities in patients with post-stroke sleep apnoea: a pilot case-control study 39
To improve awareness of stroke ameliorates the quality of stroke treatment and outcome: A pilot survey 36
Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry 35
PILOT STUDY ON MULTISLICE SPIRAL CT-ANGIOGRAPHY CAPABILITY IN DETECTING CAROTID UNSTABLE PLAQUE 34
POST STROKE SLEEP APNEA: RESULTS OF A PILOT STUDY 34
Post stroke sleep apnea hypopnea syndrome: a series of 12 consecutive stable stroke cases 31
Stroke: what happens from symptoms onset to medical intervention? 28
ROLE OF LESS WELL-DOCUMENTED RISK FACTORS ON STROKE RECURRENCE 27
LESS WELL-DOCUMENTED RISK FACTORS ROLE IN ISCHEMIC STROKE RECURRENCE AND/OR DEATH 26
I costi diretti di gestione in Stroke Unit 20
Totale 1.025
Categoria #
all - tutte 2.816
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020151 0 0 0 7 15 18 20 23 20 26 14 8
2020/202142 3 8 0 4 0 1 1 7 7 7 4 0
2021/2022261 5 10 29 7 29 27 6 34 18 20 24 52
2022/2023249 48 40 16 17 31 21 14 11 31 5 13 2
2023/202495 3 19 2 12 7 8 6 6 1 13 5 13
2024/202530 12 8 6 4 0 0 0 0 0 0 0 0
Totale 1.025